LA
PGEN icon

LexAurum Advisors’s Precigen PGEN Stock Holding History

LexAurum Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64M Sell
638,413
-51,000
-7% -$220K 0.42% 51
2026
Q1 		$2.67M Buy
+689,413
New +$2.83M 0.35% 59
2025
Q3 		$2.19M Sell
666,038
-6,505
-1% -$18.4K 0.31% 64
2025
Q2 		$955K Sell
672,543
-12,755
-2% -$18.1K 0.15% 124
2025
Q1 		$1.02M Sell
685,298
-6,246
-0.9% -$9.83K 0.2% 109
2024
Q4 		$775K Buy
691,544
+417,055
+152% +$356K 0.15% 127
2024
Q3 		$260K Buy
274,489
+33,300
+14% +$42K 0.06% 251
2024
Q2 		$381K Buy
241,189
+152,023
+170% +$221K 0.09% 191
2024
Q1 		$129K Sell
89,166
-8,600
-9% -$12.3K 0.03% 291
2023
Q4 		$131K Buy
97,766
+5,100
+6% +$5.99K 0.03% 290
2023
Q3 		$132K Sell
92,666
-9,300
-9% -$13.2K 0.04% 275
2023
Q2 		$117K Sell
101,966
-2,000
-2% -$2.36K 0.04% 262
2023
Q1 		$110K Sell
103,966
-6,005
-5% -$8.66K 0.04% 246
2022
Q4 		$167K Sell
109,971
-38,700
-26% -$66.6K 0.06% 238
2022
Q3 		$315K Sell
148,671
-4,000
-3% -$8.43K 0.12% 168
2022
Q2 		$205K Buy
152,671
+3,800
+3% +$5.64K 0.08% 230
2022
Q1 		$314K Buy
+148,871
New +$362K 0.1% 179

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LexAurum Advisors's PGEN Position: Q2 2026 in Review

LexAurum Advisors reduced its Precigen (PGEN) stake by 7.4% in Q2 2026, selling an estimated $220K and leaving 638,413 shares worth $3.64M. The position accounts for 0.42% of the portfolio, ranked #51.

LexAurum Advisors first reported a position in PGEN in Q1 2022 and has held it in 17 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • LexAurum Advisors held 638,413 shares of Precigen worth $3.64M as of Q2 2026.
  • LexAurum Advisors sold 51,000 Precigen shares in Q2 2026, an estimated $220K.
  • Precigen made up 0.42% of LexAurum Advisors's portfolio in Q2 2026, its #51 holding.
  • LexAurum Advisors first reported a position in Precigen in Q1 2022 and has held it in 17 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.